Longitudinal study of leptin levels in chronic hemodialysis patients

Nutrition Journal

Joshua Weissgarten²  Zhan Averbukh²  Leonid Feldman²  Hila Yasur¹  Ada Azar¹  Inna Sinuani²  Ilia Beberashvili² 

[1] Nutrition Department, Assaf Harofeh Medical Center, Zerifin, Affiliated to Sackler Faculty of Medicine Tel Aviv University, Israel;Nephrology Division, Assaf Harofeh Medical Center, Zerifin, Affiliated to Sackler Faculty of Medicine Tel Aviv University, Israel

关键词: Hemodialysis;    Inflammation;    Bioimpedance;    Nutrition;    Leptin;   

Others  :  829550
DOI  :  10.1186/1475-2891-10-68

 received in 2011-03-06, accepted in 2011-06-15,  发布年份 2011

【 摘 要 】

Background

The influence of serum leptin levels on nutritional status and survival in chronic hemodialysis patients remained to be elucidated. We conducted a prospective longitudinal study of leptin levels and nutritional parameters to determine whether changes of serum leptin levels modify nutritional status and survival in a cohort of prevalent hemodialysis patients.

Methods

Leptin, dietary energy and protein intake, biochemical markers of nutrition and body composition (anthropometry and bioimpedance analysis) were measured at baseline and at 6, 12, 18 and 24 months following enrollment, in 101 prevalent hemodialysis patients (37% women) with a mean age of 64.6 ± 11.5 years. Observation of this cohort was continued over 2 additional years. Changes in repeated measures were evaluated, with adjustment for baseline differences in demographic and clinical parameters.

Results

Significant reduction of leptin levels with time were observed (linear estimate: -2.5010 ± 0.57 ng/ml/2y; p < 0.001) with a more rapid decline in leptin levels in the highest leptin tertile in both unadjusted (p = 0.007) and fully adjusted (p = 0.047) models. A significant reduction in body composition parameters over time was observed, but was not influenced by leptin (leptin-by-time interactions were not significant). No significant associations were noted between leptin levels and changes in dietary protein or energy intake, or laboratory nutritional markers. Finally, cumulative incidences of survival were unaffected by the baseline serum leptin levels.

Conclusions

Thus leptin levels reflect fat mass depots, rather than independently contributing to uremic anorexia or modifying nutritional status and/or survival in chronic hemodialysis patients. The importance of such information is high if leptin is contemplated as a potential therapeutic target in hemodialysis patients.

【 授权许可】

   
2011 Beberashvili et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of Chronic Kidney Disease in the United States. JAMA 2007, 7(17):2038-2047. 298
• [2]Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergstrom J: Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998, 53(3):773-782.
• [3]Lowrie EG: Chronic dialysis treatment: Clinical outcome and related processes of care. Am J Kidney Dis 1994, 24:255-266.
• [4]Vonesh EF, Snyder JJ, Foley RN, Collins AJ: The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004, 66(6):2389-401.
• [5]Young GA, Woodrow G, Kendall S, Oldroyd B, Turney JH, Smith MA: Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition? Nephrol Dial Transplant 1997, 12:2318-2323.
• [6]Stenvinkel P: Leptin - a new hormone of definite interest for the nephrologists. Nephrol Dial Transplant 1998, 13:1099-1101.
• [7]Baskin DG, Blevins JE, Schwartz MW: How the brain regulates food intake and body weight: the role of leptin. J Pediatr Endocrinol Metab 2001, 14(Suppl 6):1417-1429.
• [8]Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV: Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998, 47(4):294-297.
• [9]Chan JL, Mantzoros CS: Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005, 366:74-85.
• [10]Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D: Leptin: Linking Obesity, the Metabolic Syndrome, and Cardiovascular Disease. Current Hypertension Reports 2008, 10:131-137.
• [11]Boden G, Chen X, Kolaczynski JW, Polansky M: Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 1997, 100:1107-1113.
• [12]Wallace M, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N: Plasma leptin and the risk of cardiovascular disease in the West Of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001, 104:3052-3056.
• [13]Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BRC, Kurnik PB, O'Connor J, Caro JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997, 51:1980-1985.
• [14]Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997, 8(9):1423-1430.
• [15]Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH: Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 2005, 115(6):1659-1665.
• [16]Wright M, Woodrow G, O'Brien S, Armstrong E, King N, Dye L, Blundell J, Brownjohn A, Turney J: Cholecystokinin and leptin: their influence upon the eating behaviour and nutrient intake of dialysis patients. Nephrol Dial Transplant 2004, 19(1):133-140.
• [17]Bossola M, Muscaritoli M, Valenza V, Panocchia N, Tazza L, Cascino A, Laviano A, Liberatori M, Lodovica Moussier M, Rossi Fanelli F, Luciani G: Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 2004, 97(3):76-82.
• [18]Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimbürger O: Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000, 11:1303-1309.
• [19]Odamaki M, Furuya R, Yoneyama T, Nishikino M, Hibi I, Miyaji K, Kumagai H: Association of the serum leptin concentration with weight loss in chronic hemodialysis patients. Am J Kidney Dis 1999, 33:361-368.
• [20]Johansen KL, Mulligan K, Tal V, Schambelan M: Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 1998, 9:1080-1084.
• [21]Nishizawa Y, Shoji T, Tanaka S, Yamashita M, Morita A, Emoto M, Tabata T, Inoue T, Morii H: Plasma leptin level and its relationship with body composition in hemodialysis patients. Am J Kidney Dis 1998, 31:655-661.
• [22]Don BR, Rosales LM, Levine NW, Kaysen GA: Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001, 59:1114-1120.
• [23]Dervisoglu E, Eraldemir C, Kalender B, Kir HM, Caglayan C: Adipocytokines Leptin and Adiponectin, and Measures of Malnutrition Inflammation in Chronic Renal Failure: Is There a Relationship? J Ren Nutr 2008, 18(4):332-337.
• [24]Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C: Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 2005, 15:345-355.
• [25]Beberashvili I, Sinuani I, Azar A, Yasur H, Feldman L, Efrati S, Averbukh Z, Weissgarten J: Nutritional and Inflammatory Status of Hemodialysis Patients in Relation to Their Body Mass Index. J Ren Nutr 2009, 19(3):238-247.
• [26]Scholze A, Rattensperger D, Zidek W, Tepel M: Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) 2007, 15:1617-1622.
• [27]Wilkens K, Brouns-Schiro K: Suggested Guidelines for Nutrition Care of Renal Patients. American Dietetic Association, Chicago, IL 1992, 40.
• [28]Depner TA, Daugirdas JT: Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996, 7:780-785.
• [29]Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C: Single prediction equation for bioelectrical impedance analysis in adults aged 20-94 years. Nutrition 2001, 17:248-253.
• [30]Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA: Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004, 66(5):2054-6031.
• [31]Iglesias P, Diez JJ, Fernandez-Reyes MJ, Bajo MA, Aguilera A, Méndez J, Codoceo R, Selgas R: Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients. Nephrol Dial Transplant 2002, 17:260-264.
• [32]Hung SC, Tung TY, Yang CS, Tarng DC: High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients. Am J Kidney Dis 2005, 45(6):1073-1083.
• [33]Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH: Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol 2007, 18(9):2517-2524.
• [34]Bossola M, Muscaritoli M, Tazza L, Panocchia N, Liberatori M, Giungi S, Tortorelli A, Rossi Fanelli F, Luciani G: Variables associated with reduced dietary intake in hemodialysis patients. J Ren Nutr 2005, 15(2):244-252.
• [35]Mark AL, Sivitz WI: Uncoupling metabolism and coupling leptin to cardiovascular disease. Arterioscler Thromb Vasc Biol 2002, 22:881-883.
• [36]Knobelspies H, Zeidler J, Hekerman P, Bamberg-Lemper S, Becker W: Mechanism of attenuation of leptin signaling under chronic ligand stimulation. BMC Biochem 2010, 8:11-2.
• [37]van Tellingen A, Grooteman MPC, Schoorl M, ter Wee PM, Bartels PCM, Schoorl M, van der Ploeg T, Nube MJ: Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers. Nephrol Dial Transplant 2004, 19:1198-1203.
• [38]Kim S, Oh KH, Chin HJ, Na KY, Kim YS, Chae DW, Ahn C, Han JS, Kim S, Joo KW: Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy. Clin Nephrol 2009, 72(6):442-448.
• [39]Kokot F, Wiecek A, Mesjasz J, Adamczak M, Spiechowicz U: Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients. Nephrol Dial Transplant 1998, 13(5):1200-1205.
• [40]Zoccali C, Tripepi G, Cambareri F, Catalano F, Finocchiaro P, Cutrupi S, Pizzini P, Testa A, Spoto B, Panuccio V, Enia G, Mallamaci F: Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. J Ren Nutr 2005, 15(1):125-130.
• [41]Teta D, Bevington A, Brown J, Pawluczyk I, Harris K, Walls J: Acidosis downregulates leptin production from cultured adipocytes through a glucose transport-dependent posttranscriptional mechanism. J Am Soc Nephrol 2003, 14:2248-2254.
• [42]Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L: A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998, 393:684-688.
• [43]Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM: Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr 2003, 77:842-846.
• [44]Chazot C, Laurent G, Charra B, Blanc C, VoVan C, Jean G, Vanel T, Terrat JC, Ruffet M: Malnutrition in long-term haemodialysis survivors. Nephrol Dial Transplant 2001, 16(1):61-69.
• [45]Bossola M, La Torre G, Giungi S, Tazza L, Vulpio C, Luciani G: Serum albumin, body weight and inflammatory parameters in chronic hemodialysis patients: a three-year longitudinal study. Am J Nephrol 2008, 28(3):405-412.
• [46]Tsai YC, Lee CT, Huang TL, Cheng BC, Kuo CC, Su Y, Ng HY, Yang CC, Chuang FR, Liao SC: Inflammatory marker but not adipokine predicts mortality among long-term hemodialysis patients. Mediators Inflamm 2007, 2007:19891.
• [47]Diez JJ, Pedro Iglesias P, Fernandez-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R: Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clinical Endocrinology 2005, 62:242-249.
• [48]Panarotto D, Maheux P: Reduction of plasma leptin during a short-term fast, an oral glucose tolerance or a meal test can be a misleading bias in clinical studies. Diabetologia 1999, 42(5):634.
• [49]Javor ED, Cochran EK, Musso C, Young JR, DePaoli AM, Gorden P: Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy. Diabetes 2005, 54:1994-2002.